Your browser doesn't support javascript.
loading
Pregabalin-induced hyperprolactinemia in a patient with fibromyalgia: A case report.
Taraktas, Aslihan; Mesci, Nilgun; Ozturk, Gulcan; Kulcu, Duygu Geler; Aydog, Ece.
Afiliação
  • Taraktas A; Department of Physical Medicine and Rehabilitation, Fatih Sultan Mehmet Training and Research Hospital, Istanbul, Turkey.
  • Mesci N; Department of Physical Medicine and Rehabilitation, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
  • Ozturk G; Department of Physical Medicine and Rehabilitation, Gebze State Hospital, Kocaeli, Turkey.
  • Kulcu DG; Department of Physical Medicine and Rehabilitation, Haydarpasa Numune Training and Research Hospital, Istanbul, Turkey.
  • Aydog E; Department of Physical Medicine and Rehabilitation, Yeditepe University Hospital, Istanbul, Turkey.
North Clin Istanb ; 3(3): 233-236, 2016.
Article em En | MEDLINE | ID: mdl-28275758
ABSTRACT
Several pharmacological and non-pharmacological modalities have been proposed for the treatment of fibromyalgia syndrome (FMS), a common rheumatic disease. Pregabalin is suggested as a first-step medication for FMS in the newest guidelines. Drowsiness, dizziness, and peripheral edema are well-known side effects of pregabalin; however, mastalgia is rarely seen. Presently described is a case of FMS in a patient who developed mastalgia and hyperprolactinemia (HPL) while taking pregabalin.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: North Clin Istanb Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Turquia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: North Clin Istanb Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Turquia